The Management of Hyperphosphatemia by Lanthanum Carbonate in Chronic Kidney Disease Patients

International Journal of Nephrology and Renovascular Disease - New Zealand
doi 10.2147/ijnrd.s15466
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Informa UK Limited

Related search

Hyperphosphatemia in Chronic Kidney Disease

Medical Council
2019English

Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease

Drugs
Pharmacology
2018English

NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in Chronic Kidney Disease

Kidney International Reports
Nephrology
2018English

Puk19 - Cost-Utility of Sucroferric Oxyhydroxide for the Treatment of Hyperphosphatemia in Chronic Kidney Disease Patients Undergoing Dialysis in Canada

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Management of Patients With Coronary Artery Disease and Chronic Kidney Disease

Continuing Cardiology Education
2017English

Motivational Interviewing to Engage Patients in Chronic Kidney Disease Management

Blood Purification
MedicineHematologyNephrology
2011English

Biophysical Approach to Chronic Kidney Disease Management in Older Patients

Nephrology @ Point of Care
2016English

Hyperphosphatemia in Chronic Kidney Disease: Patient Characteristics and Dialysis Mortality During the First Year of Dialysis

Journal of Nephrology & Therapeutics
2012English

Prevalence of Chronic Kidney Disease by Stage in Diabetic Patients

Archives of Renal Diseases and Management
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy